Schrödinger, a well-established player in the computational chemistry and drug discovery space, has recently made headlines by embracing artificial intelligence (AI). The company’s CEO, Ramy Farid, officially announced this strategic pivot during the presentation of the company's year-end results
The pharmaceutical landscape is rapidly evolving, and at the forefront of these advancements is Merck & Co.'s groundbreaking licensing agreement with Jiangsu Hengrui Pharmaceuticals, focusing on the innovative Lipoprotein(a) [Lp(a)] inhibitor, HRS-5346. This monumental $2 billion deal puts Merck in
Retinitis pigmentosa, an inherited retinal disease, is characterized by progressive vision loss over time, ultimately leading to severe visual impairment. The disease affects the retinal photoreceptor cells, where the degeneration results in the gradual loss of night vision, peripheral vision, and
Breast cancer survivors are growing in number, thanks to early detection and effective treatments. However, alongside their survival, an undercurrent of accelerated aging has been observed, raising questions about the long-term impacts of the disease and its treatments on biological aging. This
Human evolution has always captured our imagination, leading to discoveries that continuously reshape our understanding of our origins. Researchers at the University of Cambridge have made a significant breakthrough, revealing that all modern humans share DNA from two ancient populations. These
Immunovant, a biotechnology company known for its innovative treatments for autoimmune diseases, has recently announced a significant shift in its development strategy. Despite late-stage successes with its experimental drug batoclimab, the company has decided to momentarily hold back on seeking
